BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24890985)

  • 1. Radiation-induced morphoea treated with UVA-1 phototherapy.
    Lim D; Johnston S; Novakovic L; Fearfield L
    Clin Exp Dermatol; 2014 Jul; 39(5):612-5. PubMed ID: 24890985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postirradiation linear morphoea.
    Akay BN; Sanli H; Heper AO
    Clin Exp Dermatol; 2010 Jun; 35(4):e106-8. PubMed ID: 19874351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, histological and high-frequency ultrasonographic evaluation (50 MHz) of morphoea treated with ultraviolet A1 phototherapy.
    Arisi M; Lorenzi L; Incardona P; Fusano M; Zanca A; Rossi MT; Tomasi C; Calzavara-Pinton PG; Venturini M
    Clin Exp Dermatol; 2019 Apr; 44(3):270-276. PubMed ID: 29974485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Success treatment of post-irradiation morphoea with acitretin and narrowband UVB.
    Newland K; Marshman G
    Australas J Dermatol; 2012 May; 53(2):136-8. PubMed ID: 22571564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
    Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
    Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread morphoea following radiotherapy for carcinoma of the breast.
    Ardern-Jones MR; Black MM
    Clin Exp Dermatol; 2003 Mar; 28(2):160-2. PubMed ID: 12653704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
    Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
    J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma.
    Su O; Onsun N; Onay HK; Erdemoglu Y; Ozkaya DB; Cebeci F; Somay A
    Int J Dermatol; 2011 Aug; 50(8):1006-13. PubMed ID: 21781079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radio-induced breast morphoea: an unrecognized complication].
    Vigneron C; Bauer N; Waisse W; Keller A; Pop M; Clavier JB; Salze P; Noël G
    Cancer Radiother; 2014 Jan; 18(1):64-7. PubMed ID: 24309003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood.
    Gruss C; Stücker M; Kobyletzki G; Schreiber D; Altmeyer P; Kerscher M
    Br J Dermatol; 1997 Feb; 136(2):293-4. PubMed ID: 9068760
    [No Abstract]   [Full Text] [Related]  

  • 11. Morphea of the breast. Two case reports and discussion of the literature.
    Dancey AL; Waters RA
    J Plast Reconstr Aesthet Surg; 2006; 59(10):1114-7. PubMed ID: 16996439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
    Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of morphea after successful ultraviolet A1 phototherapy: A cohort study.
    Vasquez R; Jabbar A; Khan F; Buethe D; Ahn C; Jacobe H
    J Am Acad Dermatol; 2014 Mar; 70(3):481-8. PubMed ID: 24365168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment.
    Sator PG; Radakovic S; Schulmeister K; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2009 May; 60(5):786-91. PubMed ID: 19211170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phototherapy for sclerosing skin conditions.
    Teske NM; Jacobe HT
    Clin Dermatol; 2016; 34(5):614-22. PubMed ID: 27638441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose UVA phototherapy for treatment of localized scleroderma.
    Kerscher M; Volkenandt M; Gruss C; Reuther T; von Kobyletzki G; Freitag M; Dirschka T; Altmeyer P
    J Am Acad Dermatol; 1998 Jan; 38(1):21-6. PubMed ID: 9448200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced morphea-a rare but severe late effect of adjuvant breast irradiation : Case report and review of the literature.
    Partl R; Regitnig P; Tauber G; Pötscher M; Bjelic-Radisic V; Kapp KS
    Strahlenther Onkol; 2018 Nov; 194(11):1060-1065. PubMed ID: 30014236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postirradiation morphea in a breast cancer patient.
    Dubner S; Bovi J; White J; Susnik B
    Breast J; 2006; 12(2):173-6. PubMed ID: 16509846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of radiation-induced generalized morphea with prominent mucin deposition and tenderness.
    Yanaba K; Umezawa Y; Nakagawa H
    Am J Case Rep; 2015 May; 16():279-82. PubMed ID: 25958415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
    Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.